Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc R Barnard

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of the American Heart Association|May 17, 2013
P2Y12 receptor blockade augments glycoprotein IIb-IIIa antagonist inhibition of platelet activation, aggregation, and procoagulant activityMichelle A Berny-Lang, Joseph A Jakubowski, Atsuhiro Sugidachi, et al.
Veterinary Immunology and Immunopathology|April 15, 2008
Effects of physiologic agonists on canine whole blood flow cytometry assays of leukocyte-platelet aggregation and platelet activationInge Tarnow, Annemarie T Kristensen, Anne K R Krogh, et al.
Circulation|June 21, 2006
Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistanceAndrew L Frelinger, Mark I Furman, Matthew D Linden, et al.
Thrombosis Research|May 29, 2007
Cystic fibrosis heterozygotes do not have increased platelet activationInge Tarnow, Alan D Michelson, Andrew L Frelinger, et al.
Cardiovascular Surgery (London, England)|October 16, 2002
Platelet-monocyte aggregates in patients with chronic venous insufficiency remain elevated following correction of refluxMichael J Rohrer, R Brannon Claytor, Charles S C Garnette, et al.
Circulation|December 10, 2009
Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterizationAndrew L Frelinger, YouFu Li, Matthew D Linden, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|April 22, 2011
The influence of intermittent hypoxemia on platelet activation in obese patients with obstructive sleep apneaShilpa Rahangdale, Susie Yim Yeh, Victor Novack, et al.
Platelets|October 27, 2009
Nephropathy in type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivityInge Tarnow, Alan D Michelson, Marc R Barnard, et al.
Plos One|April 12, 2014
Antiplatelet activity, P2Y₁ and P2Y₁₂ inhibition, and metabolism in plasma of stereoisomers of diadenosine 5',5'″-P¹ ,P⁴-dithio-P²,P³-chloromethylenetetraphosphateHung Chang, Ivan B Yanachkov, Edward J Dix, et al.
Platelets|March 9, 2013
Platelet activation and inhibition in sickle cell disease (pains) studyAndrew L Frelinger, Joseph A Jakubowski, Julie K Brooks, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of the American Heart Association|May 17, 2013
P2Y12 receptor blockade augments glycoprotein IIb-IIIa antagonist inhibition of platelet activation, aggregation, and procoagulant activityMichelle A Berny-Lang, Joseph A Jakubowski, Atsuhiro Sugidachi, et al.
Veterinary Immunology and Immunopathology|April 15, 2008
Effects of physiologic agonists on canine whole blood flow cytometry assays of leukocyte-platelet aggregation and platelet activationInge Tarnow, Annemarie T Kristensen, Anne K R Krogh, et al.
Circulation|June 21, 2006
Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistanceAndrew L Frelinger, Mark I Furman, Matthew D Linden, et al.
Thrombosis Research|May 29, 2007
Cystic fibrosis heterozygotes do not have increased platelet activationInge Tarnow, Alan D Michelson, Andrew L Frelinger, et al.
Cardiovascular Surgery (London, England)|October 16, 2002
Platelet-monocyte aggregates in patients with chronic venous insufficiency remain elevated following correction of refluxMichael J Rohrer, R Brannon Claytor, Charles S C Garnette, et al.
Circulation|December 10, 2009
Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterizationAndrew L Frelinger, YouFu Li, Matthew D Linden, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|April 22, 2011
The influence of intermittent hypoxemia on platelet activation in obese patients with obstructive sleep apneaShilpa Rahangdale, Susie Yim Yeh, Victor Novack, et al.
Platelets|October 27, 2009
Nephropathy in type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivityInge Tarnow, Alan D Michelson, Marc R Barnard, et al.
Plos One|April 12, 2014
Antiplatelet activity, P2Y₁ and P2Y₁₂ inhibition, and metabolism in plasma of stereoisomers of diadenosine 5',5'″-P¹ ,P⁴-dithio-P²,P³-chloromethylenetetraphosphateHung Chang, Ivan B Yanachkov, Edward J Dix, et al.
Platelets|March 9, 2013
Platelet activation and inhibition in sickle cell disease (pains) studyAndrew L Frelinger, Joseph A Jakubowski, Julie K Brooks, et al.
Pageof 3